Clinical trial
Can Short Latency Afferent Inhibition Give us Clues to Better Dystonia Treatments?
NCT01435681 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Can Short Latency Afferent Inhibition Give us Clues to Better Dystonia Treatments?
- Lead sponsor
- University of Florida
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2012
- Completion date
- August 31, 2016
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dystonia, dyt 1, dyt-1, dyt1